Market Closed -
Japan Exchange
02:00:00 2024-06-14 am EDT
5-day change
1st Jan Change
2,078
JPY
+2.82%
+1.76%
+3.02%
Zeria Pharmaceutical Co., Ltd.'s Equity Buyback announced on November 4, 2021, has expired with 755,900 shares, representing 1.68% for ¥1,481.32 million.
The company expired its plan on May 13, 2022.
Zeria Pharmaceutical Co., Ltd. Provides Consolidated Earnings Guidance for the First Six Months and Full Year Ending March 31, 2025
May. 09
CI
Borsch Med Pte. Ltd. Introduces Chondroitin Supplements of Zeria Pharmaceutical Co. Ltd to Singapore for Healthy Joints
Apr. 23
CI
Zeria Pharmaceutical's Profit Up 41% in Fiscal Q1-Q3
Feb. 16
MT
Japanese Shares End Firmer on Friday on BoJ Policy Outlook
Nov. 17
MT
Zeria Pharmaceutical’s Attributable Profit Up 12.1% in Fiscal Q1 on Absence of Forex Losses
23-08-22
MT
Zeria Pharmaceutical Co., Ltd. Provides Consolidated Financial Forecast for the Six Months of 2024 and the Fiscal Year Ending March 31, 2024
23-08-21
CI
Tranche Update on Zeria Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 11, 2022.
23-05-16
CI
Zeria Pharmaceutical Co., Ltd.'s Equity Buyback announced on May 11, 2022, has closed with 263,900 shares, representing 0.6% for ¥545.29 million.
23-05-11
CI
Zeria Pharmaceutical Co., Ltd. Provides Consolidated Earnings Guidance for the First Six Months and Full Year Ending March 31, 2024
23-05-11
CI
Tranche Update on Zeria Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 11, 2022.
23-04-04
CI
Zeria Pharmaceutical's Attributable Profit Soars 48% in Fiscal Nine Months
23-02-21
MT
Zeria Pharmaceutical Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending March 31, 2023
23-02-02
CI
Tranche Update on Zeria Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 11, 2022.
23-01-06
CI
Zeria Pharmaceutical Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending March 31, 2023
22-11-02
CI
Zeria Pharmaceutical Co., Ltd.'s Equity Buyback Plan Extended till May 12, 2023.
22-11-01
CI
Tranche Update on Zeria Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 11, 2022.
22-10-04
CI
Zeria Pharmaceutical Co., Ltd. Announces Consolidated Earnings Guidance for the Six Months and Fiscal Year Ending March 31, 2023
22-08-04
CI
Tranche Update on Zeria Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 11, 2022.
22-07-05
CI
Tranche Update on Zeria Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on November 4, 2021.
22-05-15
CI
Zeria Pharmaceutical Co., Ltd.'s Equity Buyback announced on November 4, 2021, has expired with 755,900 shares, representing 1.68% for ¥1,481.32 million.
22-05-12
CI
Zeria Pharmaceutical Co., Ltd. announces an Equity Buyback for 800,000 shares, representing 1.8% for ¥1,800 million.
22-05-11
CI
Zeria Pharmaceutical Co., Ltd. Announces Consolidated Earnings Guidance for the Six Months and Fiscal Year Ending March 31, 2023
22-05-11
CI
Zeria Pharmaceutical Co., Ltd. authorizes a Buyback Plan.
22-05-10
CI
Tranche Update on Zeria Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on November 4, 2021.
22-04-01
CI
Zeria Pharmaceutical Logs Higher Profit, Revenue in Nine Months to December 2021
22-02-03
MT
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Zeria Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the development of ethical drug business, consumer healthcare business and other business. The Company operates in two business segments. The Ethical Drug segment is engaged in the research, development, manufacture and sale of ethical drugs. The Consumer Healthcare segment is engaged in the manufacture, purchase and sale of over-the-counter (OTC) drugs, health foods, quasi drugs and cosmetics related to self-medication. The others include insurance agency business and real estate business, as well as various maintenance business such as purchasing and sale of promotional materials.
More about the company
Last Close Price
2,078
JPY
Average target price
2,810
JPY
Spread / Average Target
+35.23%
Consensus
1st Jan change
Capi.
+3.02% 582M +20.37% 43.54B +19.44% 21.78B +17.85% 15.38B +25.55% 15.12B +60.99% 13.36B -0.05% 6.79B -15.02% 6.38B -8.87% 5.73B +8.17% 5.32B
Generic Pharmaceuticals
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1